Catalyst Wire Dossier Catalyst Wire Dossier

Ubrelvy

ubrogepant · AbbVie
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Ubrelvy, covering 2019-12-23 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

See pricing